Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
T cells
Preprint
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/18/2023
Remdesivir
Preprint
Approved by FDA Experimental Antiviral Jan/18/2023
BNT162b2
Preprint
Approved by FDA Experimental Vaccine Jun/22/2022
mRNA-1273
Preprint
Emergency use authorization Experimental Vaccine Jun/22/2022
REGEN-COV
Preprint
Emergency use authorization Experimental Antiviral Jun/03/2022
Convalescent plasma
Preprint
Emergency use authorization Experimental Antiviral May/16/2022
Ivermectin
Preprint
Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022
Baricitinib
Preprint
Emergency use authorization Used to treat other disease Other treatment Feb/03/2022
Dexamethasone
Preprint
Emergency use authorization Used to treat other disease Other treatment Jan/21/2022
ChAdOx1 nCoV-19
Preprint
Emergency use authorization Experimental Vaccine Jan/04/2022
Tocilizumab
Preprint
Recommended by China's NHC Guidelines Used to treat other disease Other treatment Dec/21/2021
Methylprednisolone
Preprint
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/21/2021
Emtricitabine
Preprint
Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021
Tenofovir
Preprint
Potential treatment - clinical evidence Used to treat other disease Antiviral Dec/20/2021
Metformin
Preprint
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/14/2021
Ritonavir
Preprint
Emergency use authorization Used to treat other disease Antiviral Nov/02/2021
Siltuximab
Preprint
Potential treatment - clinical evidence Used to treat other disease Other treatment Oct/29/2021
Favipiravir
Preprint
Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021
Cobimetinib
Preprint
Potential treatment - pre-clinical evidence Used to treat other disease Other treatment Sep/06/2021
Bosutinib
Preprint
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/06/2021